Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Quinn LL"'
Autor:
Anderson VE; Adaptimmune, Abingdon, Oxfordshire, UK., Brilha SS, Weber AM, Pachnio A, Wiedermann GE, Dauleh S, Ahmed T, Pope GR, Quinn LL, Docta RY, Quattrini A, Masters S, Cartwright N, Viswanathan P, Melchiori L, Rice LV, Sevko A, Gueguen C, Saini M, Tavano B, Abbott RJM, Silk JD, Laugel B, Sanderson JP, Gerry AB
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2023 May 01; Vol. 46 (4), pp. 132-144. Date of Electronic Publication: 2023 Feb 27.
Autor:
Silk JD; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom; jonathan.silk@enarabio.com joanna.brewer@adaptimmune.com., Abbott RJM; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Adams KJ; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Bennett AD; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Brett S; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and., Cornforth TV; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Crossland KL; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Figueroa DJ; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and., Jing J; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and., O'Connor C; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Pachnio A; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Patasic L; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and., Peredo CE; Cell and Gene Therapy Product Development and Supply, Analytical Development, GlaxoSmithKline, Collegeville, PA., Quattrini A; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Quinn LL; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Rust AG; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and., Saini M; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Sanderson JP; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Steiner D; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and., Tavano B; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Viswanathan P; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Wiedermann GE; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Wong R; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Jakobsen BK; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Britten CM; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and., Gerry AB; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom., Brewer JE; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom; jonathan.silk@enarabio.com joanna.brewer@adaptimmune.com.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 Jan 01; Vol. 208 (1), pp. 169-180. Date of Electronic Publication: 2021 Dec 01.
Autor:
Sanderson JP; Preclinical Research, Adaptimmune, Abingdon, UK., Crowley DJ; Preclinical Research, Adaptimmune, Abingdon, UK., Wiedermann GE; Preclinical Research, Adaptimmune, Abingdon, UK., Quinn LL; Preclinical Research, Adaptimmune, Abingdon, UK., Crossland KL; Preclinical Research, Adaptimmune, Abingdon, UK., Tunbridge HM; Preclinical Research, Adaptimmune, Abingdon, UK., Cornforth TV; Preclinical Research, Adaptimmune, Abingdon, UK., Barnes CS; Translational Sciences, Adaptimmune, Abingdon, UK., Ahmed T; Preclinical Research, Adaptimmune, Abingdon, UK., Howe K; Target Validation, Adaptimmune, Abingdon, UK., Saini M; Preclinical Research, Adaptimmune, Abingdon, UK., Abbott RJ; Preclinical Research, Adaptimmune, Abingdon, UK., Anderson VE; Preclinical Research, Adaptimmune, Abingdon, UK., Tavano B; Preclinical Research, Adaptimmune, Abingdon, UK., Maroto M; Target Validation, Adaptimmune, Abingdon, UK., Gerry AB; Preclinical Research, Adaptimmune, Abingdon, UK.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2019 Nov 24; Vol. 9 (1), pp. 1682381. Date of Electronic Publication: 2019 Nov 24 (Print Publication: 2020).
Autor:
Docta RY; Adaptimmune, Abingdon, United Kingdom., Ferronha T; Adaptimmune, Abingdon, United Kingdom., Sanderson JP; Adaptimmune, Abingdon, United Kingdom., Weissensteiner T; Adaptimmune, Abingdon, United Kingdom., Pope GR; Adaptimmune, Abingdon, United Kingdom., Bennett AD; Adaptimmune, Abingdon, United Kingdom., Pumphrey NJ; Adaptimmune, Abingdon, United Kingdom., Ferjentsik Z; Adaptimmune, Abingdon, United Kingdom., Quinn LL; Adaptimmune, Abingdon, United Kingdom., Wiedermann GE; Adaptimmune, Abingdon, United Kingdom., Anderson VE; Adaptimmune, Abingdon, United Kingdom., Saini M; Adaptimmune, Abingdon, United Kingdom., Maroto M; Adaptimmune, Abingdon, United Kingdom., Norry E; Adaptimmune, Abingdon, United Kingdom., Gerry AB; Adaptimmune, Abingdon, United Kingdom.
Publikováno v:
Hepatology (Baltimore, Md.) [Hepatology] 2019 May; Vol. 69 (5), pp. 2061-2075. Date of Electronic Publication: 2019 Feb 14.
Autor:
Williams LR; Institute of Immunology & Immunotherapy, College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Quinn LL; Institute of Immunology & Immunotherapy, College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Rowe M; Institute of Immunology & Immunotherapy, College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Zuo J; Institute of Immunology & Immunotherapy, College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom J.Zuo@bham.ac.uk.
Publikováno v:
Journal of virology [J Virol] 2015 Nov 04; Vol. 90 (2), pp. 947-58. Date of Electronic Publication: 2015 Nov 04 (Print Publication: 2016).
Autor:
Quinn LL; Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Williams LR; Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom., White C; Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Forrest C; Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Zuo J; Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom J.Zuo@bham.ac.uk., Rowe M; Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Publikováno v:
Journal of virology [J Virol] 2015 Oct 14; Vol. 90 (1), pp. 356-67. Date of Electronic Publication: 2015 Oct 14 (Print Publication: 2016).
Autor:
Quinn LL; School of Cancer Sciences and Centre for Human Virology, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, United Kingdom., Zuo J; School of Cancer Sciences and Centre for Human Virology, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, United Kingdom., Abbott RJ; School of Cancer Sciences and Centre for Human Virology, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, United Kingdom., Shannon-Lowe C; School of Cancer Sciences and Centre for Human Virology, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, United Kingdom., Tierney RJ; School of Cancer Sciences and Centre for Human Virology, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, United Kingdom., Hislop AD; School of Cancer Sciences and Centre for Human Virology, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, United Kingdom., Rowe M; School of Cancer Sciences and Centre for Human Virology, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, United Kingdom.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2014 Aug 21; Vol. 10 (8), pp. e1004322. Date of Electronic Publication: 2014 Aug 21 (Print Publication: 2014).
Autor:
Abbott RJ; School of Cancer Sciences and Medical Research Council Centre for Immune Regulation, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom., Quinn LL, Leese AM, Scholes HM, Pachnio A, Rickinson AB
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2013 Dec 01; Vol. 191 (11), pp. 5398-409. Date of Electronic Publication: 2013 Oct 21.
Autor:
Goncharova-Zapata O; Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA. ; Tel. +1-302-831-1968., Chatterjee PB; Department of Chemistry, Colorado State University, Fort Collins, CO 80523-1872, USA. Tel. +1-970-491-7635., Hou G; Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA. ; Tel. +1-302-831-1968., Quinn LL; Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA. ; Tel. +1-302-831-1968., Li M; Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA. ; Tel. +1-302-831-1968., Yehl J; Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA. ; Tel. +1-302-831-1968., Crans DC; Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA. ; Tel. +1-302-831-1968., Polenova T; Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA. ; Tel. +1-302-831-1968.
Publikováno v:
CrystEngComm [CrystEngComm] 2013 Nov 21; Vol. 15 (43).
Autor:
Misstear K; School of Cancer Sciences, CR UK Centre for Cancer Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Chanas SA, Rezaee SA, Colman R, Quinn LL, Long HM, Goodyear O, Lord JM, Hislop AD, Blackbourn DJ
Publikováno v:
Journal of virology [J Virol] 2012 Jun; Vol. 86 (11), pp. 6246-57. Date of Electronic Publication: 2012 Apr 04.